Maravai Lifesciences Holdings (MRVI) Shareholder's Equity Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Shareholder's Equity Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.40% |
| Dec 31, 2025 | -63.21% |
| Sep 30, 2025 | -29.52% |
| Jun 30, 2025 | -39.42% |
| Mar 31, 2025 | -31.79% |
| Dec 31, 2024 | -26.92% |
| Sep 30, 2024 | -31.33% |
| Jun 30, 2024 | -13.94% |
| Mar 31, 2024 | -13.68% |
| Dec 31, 2023 | -12.74% |
| Sep 30, 2023 | 6.01% |
| Jun 30, 2023 | 16.01% |
| Mar 31, 2023 | 37.65% |
| Dec 31, 2022 | 65.99% |
| Sep 30, 2022 | 84.09% |
| Jun 30, 2022 | 129.37% |
| Mar 31, 2022 | 206.00% |
| Dec 31, 2021 | 252.42% |